Work

Outcomes and Economic Impact of Switching from Anti-TNF to Anti-TNF Therapy Compared with Switching from Anti-TNF to Vedolizumab Therapy in Patients with IBD

Year: 2017

Type: article

Source: Gastroenterology

DOI: 10.1016/s0016-5085(17)32121-2

Authors: Michael V. Chiorean, Anita Afzali, Zhou Zhou, Dendy Macaulay, Joanne Rizzo, Martha Skup, Anthony Wang

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2607181849

FWCI:

Cites:

Cited by:

Related to: 10